|
G |
Akt1 |
AKT serine/threonine kinase 1 |
decreases activity |
ISO |
Phytic Acid results in decreased activity of AKT1 protein |
CTD |
PMID:15868430 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
ISO |
Phytic Acid inhibits the reaction [Asbestos, Amosite results in increased activity of CASP3 protein] |
CTD |
PMID:11329530 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp9 |
caspase 9 |
multiple interactions |
ISO |
Phytic Acid inhibits the reaction [Asbestos, Amosite results in increased activity of CASP9 protein] |
CTD |
PMID:12540492 PMID:14766669 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
multiple interactions |
EXP |
[Phytic Acid co-treated with Inositol] inhibits the reaction [Streptozocin results in decreased activity of CAT protein] |
CTD |
PMID:28757134 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccnd1 |
cyclin D1 |
multiple interactions |
ISO |
Phytic Acid inhibits the reaction [Urethane results in increased expression of CCND1 mRNA]; Phytic Acid inhibits the reaction [Urethane results in increased expression of CCND1 protein] |
CTD |
PMID:22797328 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
multiple interactions |
ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phytic Acid inhibits the reaction [Glucose results in increased expression of CDKN1A mRNA]]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phytic Acid inhibits the reaction [Glucose results in increased expression of CDKN1A protein]]; Phytic Acid inhibits the reaction [Glucose results in increased expression of CDKN1A mRNA]; Phytic Acid inhibits the reaction [Glucose results in increased expression of CDKN1A protein] |
CTD |
PMID:38000455 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
decreases expression |
ISO |
Phytic Acid results in decreased expression of CDKN1B protein |
CTD |
PMID:15868430 |
|
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
multiple interactions affects methylation |
ISO |
Phytic Acid inhibits the reaction [Ethylnitrosourea results in decreased expression of CDKN2A] Phytic Acid affects the methylation of CDKN2A promoter |
CTD |
PMID:21154115 |
|
NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
multiple interactions |
ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phytic Acid inhibits the reaction [Glucose results in decreased expression of COL1A1 mRNA]]; Phytic Acid inhibits the reaction [Glucose results in decreased expression of COL1A1 mRNA] |
CTD |
PMID:38000455 |
|
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Ctsb |
cathepsin B |
multiple interactions |
EXP |
Phytic Acid inhibits the reaction [Isoproterenol results in increased activity of CTSB protein] |
CTD |
PMID:25560919 |
|
NCBI chr15:37,389,636...37,410,508
Ensembl chr15:37,389,629...37,410,500
|
|
G |
Ctsd |
cathepsin D |
multiple interactions |
EXP |
Phytic Acid inhibits the reaction [Isoproterenol results in increased activity of CTSD protein] |
CTD |
PMID:25560919 |
|
NCBI chr 1:197,527,467...197,539,343
Ensembl chr 1:197,527,467...197,539,488
|
|
G |
Egfr |
epidermal growth factor receptor |
multiple interactions |
ISO |
Phytic Acid inhibits the reaction [Asbestos, Crocidolite results in decreased phosphorylation of EGFR protein] |
CTD |
PMID:15626777 |
|
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Ehmt2 |
euchromatic histone lysine methyltransferase 2 |
multiple interactions |
ISO |
Phytic Acid inhibits the reaction [Urethane results in increased expression of EHMT2 mRNA]; Phytic Acid inhibits the reaction [Urethane results in increased expression of EHMT2 protein] |
CTD |
PMID:25168426 |
|
NCBI chr20:3,919,623...3,936,751
Ensembl chr20:3,919,624...3,941,547
|
|
G |
Ezh2 |
enhancer of zeste 2 polycomb repressive complex 2 subunit |
multiple interactions |
ISO |
Phytic Acid inhibits the reaction [Urethane results in increased expression of EZH2 mRNA]; Phytic Acid inhibits the reaction [Urethane results in increased expression of EZH2 protein] |
CTD |
PMID:25168426 |
|
NCBI chr 4:76,624,399...76,687,362
Ensembl chr 4:76,624,399...76,687,362
|
|
G |
Foxo1 |
forkhead box O1 |
multiple interactions |
ISO |
[resveratrol co-treated with Quercetin co-treated with Phytic Acid] results in increased expression of FOXO1 mRNA |
CTD |
PMID:18657603 |
|
NCBI chr 2:136,312,168...136,390,603
Ensembl chr 2:136,312,168...136,387,790
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
multiple interactions |
EXP |
[Phytic Acid co-treated with Inositol] inhibits the reaction [Streptozocin results in decreased activity of G6PD protein] |
CTD |
PMID:28757134 |
|
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
|
|
G |
Glb1 |
galactosidase, beta 1 |
multiple interactions |
EXP ISO |
Phytic Acid inhibits the reaction [Isoproterenol results in increased activity of GLB1 protein] 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phytic Acid inhibits the reaction [Glucose results in increased expression of GLB1 protein]]; Phytic Acid inhibits the reaction [Glucose results in increased expression of GLB1 protein] |
CTD |
PMID:25560919 PMID:38000455 |
|
NCBI chr 8:114,085,508...114,158,127
Ensembl chr 8:114,085,508...114,158,127
|
|
G |
Gusb |
glucuronidase, beta |
multiple interactions |
EXP |
Phytic Acid inhibits the reaction [Isoproterenol results in increased activity of GUSB protein] |
CTD |
PMID:25560919 |
|
NCBI chr12:26,701,188...26,714,718
Ensembl chr12:26,697,951...26,726,905
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
Phytic Acid inhibits the reaction [Glucose results in increased expression of IL1B protein] |
CTD |
PMID:38000455 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
ISO |
Phytic Acid inhibits the reaction [Urethane results in increased expression of IL6 mRNA]; Phytic Acid inhibits the reaction [Urethane results in increased expression of IL6 protein] |
CTD |
PMID:22797328 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
decreases activity multiple interactions |
ISO EXP |
Phytic Acid results in decreased activity of MAPK1 protein [resveratrol co-treated with Phytic Acid co-treated with ferulic acid co-treated with Quercetin] results in increased phosphorylation of MAPK1 protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phytic Acid inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein]]; Phytic Acid inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:15868430 PMID:21203465 PMID:38000455 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
decreases activity multiple interactions |
ISO EXP |
Phytic Acid results in decreased activity of MAPK3 protein [resveratrol co-treated with Phytic Acid co-treated with ferulic acid co-treated with Quercetin] results in increased phosphorylation of MAPK3 protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phytic Acid inhibits the reaction [Glucose results in increased phosphorylation of MAPK3 protein]]; Phytic Acid inhibits the reaction [Glucose results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:15868430 PMID:21203465 PMID:38000455 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mir101a |
microRNA 101a |
multiple interactions |
EXP |
[resveratrol co-treated with Phytic Acid co-treated with ferulic acid co-treated with Quercetin] results in increased expression of MIR101A mRNA |
CTD |
PMID:21203465 |
|
NCBI chr 5:115,966,332...115,966,406
Ensembl chr 5:115,966,328...115,966,410
|
|
G |
Mir10a |
microRNA 10a |
multiple interactions |
EXP |
[resveratrol co-treated with Phytic Acid co-treated with ferulic acid co-treated with Quercetin] results in increased expression of MIR10A mRNA |
CTD |
PMID:21203465 |
|
NCBI chr10:81,283,171...81,283,280
Ensembl chr10:81,283,171...81,283,280
|
|
G |
Mir138-1 |
microRNA 138-1 |
multiple interactions |
ISO |
Phytic Acid inhibits the reaction [Urethane results in decreased expression of MIR138-1 mRNA] |
CTD |
PMID:25168426 |
|
NCBI chr 8:122,300,966...122,301,064
Ensembl chr 8:122,300,966...122,301,064
|
|
G |
Mir181c |
microRNA 181c |
multiple interactions |
EXP |
[resveratrol co-treated with Phytic Acid co-treated with ferulic acid co-treated with Quercetin] results in increased expression of MIR181C mRNA |
CTD |
PMID:21203465 |
|
NCBI chr19:23,983,523...23,983,628
Ensembl chr19:23,983,523...23,983,628
|
|
G |
Mir20b |
microRNA 20b |
multiple interactions |
EXP |
[resveratrol co-treated with Phytic Acid co-treated with ferulic acid co-treated with Quercetin] results in decreased expression of MIR20B mRNA |
CTD |
PMID:21203465 |
|
NCBI chr X:132,422,211...132,422,282
Ensembl chr X:132,422,211...132,422,282
|
|
G |
Mir21 |
microRNA 21 |
multiple interactions |
EXP |
[resveratrol co-treated with Phytic Acid co-treated with ferulic acid co-treated with Quercetin] results in increased expression of MIR21 mRNA |
CTD |
PMID:21203465 |
|
NCBI chr10:71,405,257...71,405,348
Ensembl chr10:71,405,257...71,405,348
|
|
G |
Mir214 |
microRNA 214 |
multiple interactions |
EXP |
[Resveratrol co-treated with Phytic Acid co-treated with ferulic acid co-treated with Quercetin] results in increased expression of MIR214 mRNA |
CTD |
PMID:21203465 |
|
NCBI chr13:74,588,374...74,588,481
Ensembl chr13:74,588,372...74,588,481
|
|
G |
Mir25 |
microRNA 25 |
multiple interactions |
EXP |
[resveratrol co-treated with Phytic Acid co-treated with ferulic acid co-treated with Quercetin] results in increased expression of MIR25 mRNA |
CTD |
PMID:21203465 |
|
NCBI chr12:17,042,932...17,043,015
Ensembl chr12:17,042,932...17,043,015
|
|
G |
Mir27b |
microRNA 27b |
multiple interactions |
EXP |
[resveratrol co-treated with Phytic Acid co-treated with ferulic acid co-treated with Quercetin] results in decreased expression of MIR27B mRNA |
CTD |
PMID:21203465 |
|
NCBI chr17:1,813,427...1,813,523
Ensembl chr17:1,813,426...1,813,529
|
|
G |
Mir324 |
microRNA 324 |
multiple interactions |
EXP |
[resveratrol co-treated with Phytic Acid co-treated with ferulic acid co-treated with Quercetin] results in increased expression of MIR324 mRNA |
CTD |
PMID:21203465 |
|
NCBI chr10:54,734,680...54,734,762
Ensembl chr10:54,734,678...54,734,766
|
|
G |
Mir339 |
microRNA 339 |
multiple interactions |
EXP |
[resveratrol co-treated with Phytic Acid co-treated with ferulic acid co-treated with Quercetin] results in increased expression of MIR339 mRNA |
CTD |
PMID:21203465 |
|
NCBI chr12:15,277,546...15,277,641
Ensembl chr12:15,277,546...15,277,641
|
|
G |
Mir450a1 |
microRNA 450a-1 |
multiple interactions |
EXP |
[resveratrol co-treated with Phytic Acid co-treated with ferulic acid co-treated with Quercetin] results in increased expression of MIR450A1 mRNA |
CTD |
PMID:21203465 |
|
NCBI chr X:132,801,380...132,801,470
Ensembl chr X:132,801,380...132,801,470
|
|
G |
Mir760 |
microRNA 760 |
multiple interactions |
EXP |
[resveratrol co-treated with Phytic Acid co-treated with ferulic acid co-treated with Quercetin] results in increased expression of MIR760 mRNA |
CTD |
PMID:21203465 |
|
NCBI chr 2:210,392,616...210,392,695
Ensembl chr 2:210,392,616...210,392,695
|
|
G |
Mlh1 |
mutL homolog 1 |
multiple interactions affects methylation |
ISO |
Phytic Acid inhibits the reaction [Ethylnitrosourea results in increased expression of MLH1] Phytic Acid affects the methylation of MLH1 promoter |
CTD |
PMID:21154115 |
|
NCBI chr 8:111,196,468...111,233,721
Ensembl chr 8:111,196,468...111,233,617
|
|
G |
Naglu |
N-acetyl-alpha-glucosaminidase |
multiple interactions |
EXP |
Phytic Acid inhibits the reaction [Isoproterenol results in increased activity of NAGLU protein] |
CTD |
PMID:25560919 |
|
NCBI chr10:86,001,545...86,009,049
Ensembl chr10:86,001,566...86,008,972
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions |
ISO |
Phytic Acid inhibits the reaction [Glucose results in decreased expression of NFE2L2 protein] |
CTD |
PMID:38000455 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
multiple interactions |
ISO |
Phytic Acid inhibits the reaction [Urethane results in decreased expression of NFKB1 mRNA]; Phytic Acid inhibits the reaction [Urethane results in decreased expression of NFKB1 protein]; Phytic Acid inhibits the reaction [Urethane results in increased expression of NFKB1 mRNA]; Phytic Acid inhibits the reaction [Urethane results in increased expression of NFKB1 protein] |
CTD |
PMID:22797328 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions |
ISO |
Phytic Acid inhibits the reaction [Asbestos, Amosite results in increased activity of PARP1 protein]; Phytic Acid inhibits the reaction [Smoke analog results in increased activity of PARP1 protein] |
CTD |
PMID:11217149 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pdk4 |
pyruvate dehydrogenase kinase 4 |
multiple interactions |
ISO |
[resveratrol co-treated with Quercetin co-treated with Phytic Acid] results in increased expression of PDK4 mRNA |
CTD |
PMID:18657603 |
|
NCBI chr 4:33,591,796...33,601,798
Ensembl chr 4:33,589,799...33,601,850
|
|
G |
Ppargc1a |
PPARG coactivator 1 alpha |
multiple interactions |
ISO |
[resveratrol co-treated with Quercetin co-treated with Phytic Acid] results in increased expression of PPARGC1A mRNA |
CTD |
PMID:18657603 |
|
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
|
|
G |
Prkcd |
protein kinase C, delta |
multiple interactions |
ISO |
Phytic Acid results in increased expression of and results in increased activity of and affects the localization of PRKCD protein |
CTD |
PMID:15868430 |
|
NCBI chr16:5,769,217...5,799,380
Ensembl chr16:5,769,215...5,799,352
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions affects methylation |
ISO |
Phytic Acid inhibits the reaction [Ethylnitrosourea results in increased expression of PTGS2]; Phytic Acid inhibits the reaction [Urethane results in increased expression of PTGS2 mRNA]; Phytic Acid inhibits the reaction [Urethane results in increased expression of PTGS2 protein] Phytic Acid affects the methylation of PTGS2 promoter |
CTD |
PMID:21154115 PMID:22797328 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
decreases phosphorylation |
ISO |
Phytic Acid results in decreased phosphorylation of RB1 protein |
CTD |
PMID:15868430 |
|
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
Phytic Acid inhibits the reaction [Urethane results in increased expression of RELA mRNA]; Phytic Acid inhibits the reaction [Urethane results in increased expression of RELA protein] Phytic Acid inhibits the reaction [Glucose results in increased phosphorylation of RELA protein] |
CTD |
PMID:22797328 PMID:38000455 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Runx2 |
RUNX family transcription factor 2 |
multiple interactions |
ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phytic Acid inhibits the reaction [Glucose results in decreased expression of RUNX2 mRNA]]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phytic Acid inhibits the reaction [Glucose results in decreased expression of RUNX2 protein]]; Phytic Acid inhibits the reaction [Glucose results in decreased expression of RUNX2 mRNA]; Phytic Acid inhibits the reaction [Glucose results in decreased expression of RUNX2 protein] |
CTD |
PMID:38000455 |
|
NCBI chr 9:16,167,504...16,492,826
Ensembl chr 9:16,167,482...16,492,167
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
multiple interactions |
ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phytic Acid inhibits the reaction [Glucose results in decreased expression of SPP1 mRNA]]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phytic Acid inhibits the reaction [Glucose results in decreased expression of SPP1 protein]]; Phytic Acid inhibits the reaction [Glucose results in decreased expression of SPP1 mRNA]; Phytic Acid inhibits the reaction [Glucose results in decreased expression of SPP1 protein] |
CTD |
PMID:38000455 |
|
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
multiple interactions |
ISO |
Phytic Acid inhibits the reaction [Urethane results in increased expression of and results in increased phosphorylation of STAT3 protein]; Phytic Acid inhibits the reaction [Urethane results in increased expression of STAT3 mRNA] |
CTD |
PMID:22797328 |
|
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Suv39h1 |
SUV39H1 histone lysine methyltransferase |
multiple interactions |
ISO |
Phytic Acid inhibits the reaction [Urethane results in increased expression of SUV39H1 mRNA]; Phytic Acid inhibits the reaction [Urethane results in increased expression of SUV39H1 protein] |
CTD |
PMID:25168426 |
|
NCBI chr X:14,421,028...14,433,993
Ensembl chr X:14,421,109...14,433,982
|
|
G |
Suv39h1-ps1 |
SUV39H1 histone lysine methyltransferase, pseudogene 1 |
multiple interactions |
ISO |
Phytic Acid inhibits the reaction [Urethane results in increased expression of SUV39H1 mRNA]; Phytic Acid inhibits the reaction [Urethane results in increased expression of SUV39H1 protein] |
CTD |
PMID:25168426 |
|
NCBI chr X:141,792,589...141,795,257
|
|
G |
Tlr4 |
toll-like receptor 4 |
multiple interactions |
ISO |
Phytic Acid inhibits the reaction [Glucose results in increased expression of TLR4 protein] |
CTD |
PMID:38000455 |
|
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
Phytic Acid inhibits the reaction [Glucose results in increased expression of TNF protein] |
CTD |
PMID:38000455 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions |
ISO EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phytic Acid inhibits the reaction [Glucose results in increased expression of TP53 mRNA]]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phytic Acid inhibits the reaction [Glucose results in increased expression of TP53 protein]]; Phytic Acid inhibits the reaction [Asbestos, Amosite results in increased expression of TP53 mRNA]; Phytic Acid inhibits the reaction [Asbestos, Amosite results in increased expression of TP53 protein]; Phytic Acid inhibits the reaction [Glucose results in increased expression of TP53 mRNA]; Phytic Acid inhibits the reaction [Glucose results in increased expression of TP53 protein] |
CTD |
PMID:16357363 PMID:38000455 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Ucp3 |
uncoupling protein 3 |
multiple interactions |
ISO |
[resveratrol co-treated with Quercetin co-treated with Phytic Acid] results in increased expression of UCP3 mRNA |
CTD |
PMID:18657603 |
|
NCBI chr 1:154,815,777...154,828,764
Ensembl chr 1:154,815,777...154,828,762
|
|
G |
Xdh |
xanthine dehydrogenase |
decreases activity |
EXP |
Phytic Acid results in decreased activity of XDH protein |
CTD |
PMID:14738912 |
|
NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
|
|